You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RARE Sale Disclosure
Horn Howard · SEC Form 4 · Filed Jun 1, 2026
Sale
Calculated transaction value
$110.6K
Horn Howard Chief Financial Officer
RARE
Transaction date
Jun 1, 2026
Public filing date
Jun 1, 2026
Filing lag
Filed same day
RARE daily price context
Close on/before transaction
$22.85
Jun 1, 2026
First close after public filing
$21.78
Jun 2, 2026
30-day return after filing
+48.67%
Through Jul 1, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,653 shares @ $23.77
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001786335-26-000002
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$110.6K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. RARE Current | Sale | Jun 1, 2026 | $110.6K |